WHO Model List of Essential Medicines 2019 | Listas | Listas Anotadas de Medicamentos e Dispositivos

01. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES (2019)

Medicamento	Forma farmacêutica	Composição
halothane	inhalation	N/A
isoflurane	inhalation	N/A
nitrous oxide	inhalation	N/A
oxygen	inhalation (medicine gas)	N/A

Medicamento	Forma farmacêutica	Composição
ketamine	Injection	50 mg (as hydrochloride)/mL in 10-mL vial
propofol	Injection	20 mg/mL
propofol	Injection	10 mg/mL

Medicamento	Forma farmacêutica	Composição	Observações
bupivacaine	Injection for spinal anaesthesia	0.5% (hydrochloride) in 4-ml ampoule to be mixed with 7.5% glucose solution	e
bupivacaine	Injection	0.25% (hydrochloride) in vial	e
bupivacaine	Injection	0.5% (hydrochloride) in vial	e
lidocaine	Injection for spinal anaesthesia	5% (hydrochloride) in 2-ml ampoule to be mixed with 7.5% glucose solution	e
lidocaine	topical forms	2% to 4% (hydrochloride)	e
lidocaine	Injection	1% (hydrochloride) in vial	e
lidocaine	Injection	2% (hydrochloride) in vial	e
lidocaine + epinephrine (adrenaline)	Injection	2% (hydrochloride or sulfate) + epinephrine 1:200 000 in vial
lidocaine + epinephrine (adrenaline)	Injection	1% (hydrochloride or sulfate) + epinephrine 1:200 000 in vial
lidocaine + epinephrine (adrenaline)	dental cartridge	2% (hydrochloride) + epinephrine 1:80 000

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
ephedrine	Injection	30 mg (hydrochloride)/ml in 1-ml ampoule

Medicamento	Forma farmacêutica	Composição	Observações
atropine	Injection	1 mg (sulfate) in 1-ml ampoule
midazolam	Injection	1 mg/ml	e
midazolam	oral liquid	2 mg/ml	c2 e
midazolam	tablet	7.5 mg	e
midazolam	tablet	15 mg	e
morphine	Injection	10 mg (sulfate or hydrochloride) in 1-ml ampoule

Medicamento	Forma farmacêutica	Composição	Observações
oxygen	N/A	N/A

02. MEDICINES FOR PAIN AND PALLIATIVE CARE

Medicamento	Forma farmacêutica	Composição	Observações
acetylsalicylic acid	Suppository	50 mg to 150 mg
acetylsalicylic acid	tablet	100 mg to 500 mg
acetylsalicylic acid	Suppository	50 mg to 150 mg	c1
acetylsalicylic acid	tablet	100 mg to 500 mg	c1
ibuprofen	oral liquid	200 mg/5 mL	a
ibuprofen	tablet	200 mg	a
ibuprofen	tablet	400 mg	a
ibuprofen	tablet	600 mg
paracetamol	oral liquid	125 mg/5 ml
paracetamol	Suppository	100 mg
paracetamol	tablet	100 mg to 500 mg
paracetamol	oral liquid	120 mg/5 mL

Medicamento	Forma farmacêutica	Composição
codeine	tablet	30 mg (phosphate)
fentanyl	patch	12 mcg/hr
fentanyl	patch	25 mcg/hr
fentanyl	patch	50 mcg/hr
fentanyl	patch	75 mcg/hr
fentanyl	patch	100 mcg/hr
morphine	Injection	10 mg (sulfate or hydrochloride) in 1-ml ampoule
morphine	oral liquid	10 mg (hydrochloride or sulfate)/5 ml
morphine	tablet	10 mg - 200 mg (morphine sulfate)
morphine	tablet (prolonged release)	10 mg (morphine sulfate)
morphine	granules (modified release) (to mix with water)	200 mg
morphine	granules (modified release) (to mix with water)	20 mg

Lista complementar

Medicamento	Forma farmacêutica	Composição
methadone	tablet	5mg
methadone	tablet	10mg
methadone	oral liquid	5 mg/5 ml (hydrochloride)
methadone	oral liquid	10 mg/5 ml (hydrochloride)
methadone	concentrate for oral liquid	5 mg/ml (hydrochloride)
methadone	concentrate for oral liquid	10 mg/ml (hydrochloride)

Medicamento	Forma farmacêutica	Composição	Observações
amitriptyline	tablet	10 mg
amitriptyline	tablet	25 mg
amitriptyline	tablet	75 mg
cyclizine	tablet	50 mg
cyclizine	Injection	50 mg/ml
dexamethasone	Injection	4 mg/mL in 1-mL ampoule (as disodium phosphate salt)
dexamethasone	oral liquid	2 mg/5 mL
dexamethasone	tablet	2 mg
dexamethasone	tablet	4 mg
dexamethasone	Injection	4 mg/mL in 1-mL ampoule (as disodium phosphate salt)
diazepam	Injection	5 mg/mL
diazepam	oral liquid	2 mg/5 mL
diazepam	rectal solution	2.5 mg
diazepam	rectal solution	5 mg
diazepam	rectal solution	10 mg
diazepam	tablet	5 mg
diazepam	tablet	10 mg
docusate sodium	capsule	100 mg
docusate sodium	oral liquid	50 mg/5 ml
fluoxetine	solid oral dosage form	20 mg (as hydrochloride)	a
haloperidol	Injection	5 mg/mL in 1-mL ampoule
haloperidol	oral liquid	2 mg/mL
haloperidol	solid oral dosage form	0.5 mg
haloperidol	solid oral dosage form	2 mg
haloperidol	solid oral dosage form	5 mg
hyoscine butylbromide	Injection	20 mg/ml
hyoscine hydrobromide	Injection	400 mcg/mL	c1
hyoscine hydrobromide	Injection	600 mcg/mL	c1
hyoscine hydrobromide	transdermal patches	1 mg/72 hours	c1
lactulose	oral liquid	3.1-3.7 g/5 ml	c1
loperamide	solid oral dosage form	2mg
metoclopramide	Injection	5 mg (hydrochloride)/mL in 2-mL ampoule
metoclopramide	oral liquid	5 mg/5 mL
metoclopramide	solid oral dosage form	10 mg (hydrochloride)
midazolam	Injection	1 mg/ml
midazolam	Injection	5 mg/mL
midazolam	solid oral dosage form	7.5 mg
midazolam	solid oral dosage form	15 mg
midazolam	oral liquid	2 mg/ml	c1
ondansetron	Injection	2 mg base/ml in 2-ml ampoule (as hydrochloride)	a c1
ondansetron	oral liquid	4 mg base/5 ml	a c1
ondansetron	solid oral dosage form	Eq 4 mg base	a c1
ondansetron	solid oral dosage form	Eq 8 mg base	a c1
senna	oral liquid	7.5 mg/5 ml

03. Antiallergics and medicines used in anaphylaxis

Medicamento	Forma farmacêutica	Composição	Observações
dexamethasone	Injection	4 mg/mL in 1-mL ampoule (as disodium phosphate salt)
epinephrine (adrenaline)	Injection	1 mg (as hydrochloride or hydrogen tartrate) in 1-ml ampoule
hydrocortisone	Powder for injection	100 mg (as sodium succinate) in vial
loratadine	tablet	10 mg	e
loratadine	oral liquid	1mg/ml	e
prednisolone	oral liquid	5 mg/mL	c2 e
prednisolone	tablet	5 mg	e
prednisolone	tablet	25 mg	e

04. Antidotes and other substances used in poisonings

Medicamento	Forma farmacêutica	Composição	Observações
charcoal, activated	Powder	N/A

Medicamento	Forma farmacêutica	Composição	Observações
acetylcysteine	Injection	200 mg/ml in 10-ml ampoule
acetylcysteine	oral liquid	10%	c2
acetylcysteine	oral liquid	20%	c2
atropine	Injection	1 mg (sulfate) in 1-ml ampoule
calcium gluconate	Injection	100 mg/mL in 10-mL ampoule
methylthioninium chloride (methylene blue)	Injection	10 mg/ml in 10-ml ampoule
naloxone	Injection	400 mcg (hydrochloride) in 1-mL ampoule
penicillamine	solid oral dosage form	250 mg
potassium ferric hexacyano-ferrate(II) - 2H20 (Prussian blue)	powder for oral administration	N/A
sodium nitrite	Injection	30 mg/mL in 10-mL ampoule
sodium thiosulfate	Injection	250 mg/mL in 50-mL ampoule

Lista complementar

Medicamento	Forma farmacêutica	Composição
deferoxamine	Powder for injection	500 mg (mesilate) in vial
dimercaprol	Injection in oil	50 mg/mL in 2-mL ampoule
fomepizole	Injection	5 mg/ml (sulfate) in 20 ml ampoule or 1 g/ ml (base) in 1.5 ml ampoule
sodium calcium edetate	Injection	200 mg/ml in 5-ml ampoule
succimer	solid oral dosage form	100 mg

05. Anticonvulsants/antiepileptics

Medicamento	Forma farmacêutica	Composição	Observações
carbamazepine	oral liquid	100 mg/5 ml
carbamazepine	tablet (chewable)	100 mg
carbamazepine	tablet (chewable)	200 mg
carbamazepine	tablet (scored)	100 mg
carbamazepine	tablet (scored)	200 mg
diazepam	Gel	5 mg/mL in 0.5-mL tubes
diazepam	Gel	5 mg/mL in 2-mL tubes
diazepam	Gel	5 mg/mL in 4-mL tubes
diazepam	rectal solution	5 mg/mL in 0.5-mL tubes
diazepam	rectal solution	5 mg/mL in 2-mL tubes
diazepam	rectal solution	5 mg/mL in 4-mL tubes
lamotrigine	Chewable, dispersible	200 mg
lamotrigine	Chewable, dispersible	2 mg
lamotrigine	Chewable, dispersible	5 mg
lamotrigine	Chewable, dispersible	25 mg
lamotrigine	Chewable, dispersible	50 mg
lamotrigine	Chewable, dispersible	100 mg
lamotrigine	tablet	25 mg
lamotrigine	tablet	200 mg
lamotrigine	tablet	100 mg
lamotrigine	tablet	50 mg
lorazepam	parenteral formulation	2 mg/ml in 1-ml ampoule	e
lorazepam	parenteral formulation	4 mg/ml in 1-ml ampoule	e
magnesium sulfate	Injection	500 mg/mL in 2-mL ampoule
magnesium sulfate	Injection	500 mg/mL in 10-mL ampoule
midazolam	Oromucosal administration	5 mg/ ml
midazolam	Oromucosal administration	10 mg/ ml
midazolam	Ampoule	1 mg/ ml
midazolam	Ampoule	10 mg/ ml
phenobarbital	Injection	200 mg/mL (sodium)
phenobarbital	oral liquid	15 mg/5 mL
phenobarbital	tablet	15 mg to 100 mg
phenytoin	Injection	50 mg/mL in 5-mL vial (sodium salt)
phenytoin	oral liquid	25 mg to 30 mg/5 mL
phenytoin	solid oral dosage form	25 mg (sodium salt)
phenytoin	solid oral dosage form	50 mg (sodium salt)
phenytoin	solid oral dosage form	100 mg (sodium salt)
phenytoin	tablet (chewable)	50 mg
valproic acid (sodium valproate)	oral liquid	200 mg/5 ml
valproic acid (sodium valproate)	tablet (crushable)	100 mg
valproic acid (sodium valproate)	tablet (enteric-coated)	200 mg (sodium valproate)
valproic acid (sodium valproate)	tablet (enteric-coated)	500 mg (sodium valproate)

Lista complementar

Medicamento	Forma farmacêutica	Composição
ethosuximide	capsule	250 mg
ethosuximide	oral liquid	250 mg/5 ml
valproic acid (sodium valproate)	Injection	100 mg/ml in 4 ml ampoule
valproic acid (sodium valproate)	Injection	100 mg/ml in 10 ml ampoule

06. Anti-infective medicines

Medicamento	Forma farmacêutica	Composição
albendazole	tablet (chewable)	400 mg
ivermectin	tablet (scored)	3 mg
levamisole	tablet	50 mg (as hydrochloride)
levamisole	tablet	150 mg (as hydrochloride)
mebendazole	tablet (chewable)	100 mg
mebendazole	tablet (chewable)	500 mg
niclosamide	tablet (chewable)	500 mg
praziquantel	tablet	150 mg
praziquantel	tablet	600 mg
pyrantel	oral liquid	50 mg (as embonate or pamoate)/ml
pyrantel	tablet (chewable)	250 mg (as embonate or pamoate)

Medicamento	Forma farmacêutica	Composição
albendazole	tablet (chewable)	400 mg
diethylcarbamazine	tablet	50 mg (dihydrogen citrate)
diethylcarbamazine	tablet	100 mg (dihydrogen citrate)
ivermectin	tablet (scored)	3 mg

Medicamento	Forma farmacêutica	Composição	Observações
praziquantel	tablet	600 mg
triclabendazole	tablet	250 mg

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
oxamniquine	capsule	250 mg
oxamniquine	oral liquid	250 mg/5 ml

Medicamento	Forma farmacêutica	Composição	Observações
amikacin	Injection	250 mg (as sulfate)/mL in 2-mL vial
amoxicillin	Powder for injection	250 mg (as sodium) in vial
amoxicillin	powder for oral liquid	125 mg (as trihydrate)/5 mL
amoxicillin	powder for oral liquid	250 mg (as trihydrate)/5 mL	c2
amoxicillin	solid oral dosage form	250 mg (as trihydrate)
amoxicillin	solid oral dosage form	500 mg (as trihydrate)
amoxicillin	Powder for injection	500 mg (as sodium) in vial
amoxicillin	Powder for injection	1 g (as sodium) in vial
amoxicillin	Powder for injection	250 mg (as sodium) in vial
amoxicillin + clavulanic acid	oral liquid	125 mg amoxicillin + 31.25 mg clavulanic acid/5 ml
amoxicillin + clavulanic acid	oral liquid	250 mg amoxicillin + 62.5 mg clavulanic acid/5 ml	c2
amoxicillin + clavulanic acid	tablet	500 mg (as trihydrate) + 125 mg (as potassium salt)
amoxicillin + clavulanic acid	Powder for injection	500 mg (as sodium) + 100 mg (as potassium salt) in vial
amoxicillin + clavulanic acid	Powder for injection	1000 mg (as sodium) + 200 mg (as potassium salt) in vial
ampicillin	Powder for injection	500 mg (as sodium salt) in vial
ampicillin	Powder for injection	1 g (as sodium salt) in vial
benzathine benzylpenicillin	Powder for injection	900 mg benzylpenicillin (= 1.2 million IU) in 5-ml vial	c2
benzathine benzylpenicillin	Powder for injection	1.44 g benzylpenicillin (= 2.4 million IU) in 5-ml vial
benzylpenicillin	Powder for injection	600 mg (= 1 million IU) (sodium or potassium salt) in vial
benzylpenicillin	Powder for injection	3 g (= 5 million IU) (sodium or potassium salt) in vial
cefalexin	powder for reconstitution with water	125 mg/5 mL (anhydrous)	c2
cefalexin	powder for reconstitution with water	250 mg/5 mL (anhydrous)	c2
cefalexin	solid oral dosage form	250 mg (as monohydrate)
cefazolin	Powder for injection	1 g (as sodium salt) in vial	a e
chloramphenicol	oral liquid	150 mg )as palmitate)/ 5 ml
chloramphenicol	Oily suspension for injection	0.5 g (as sodium succinate) / ml in 2 ml ampoule
chloramphenicol	Powder for injection	1 g (sodium succinate) in vial
Chloranfenicol	capsule	250 mg
clindamycin	capsule	150 mg (as hydrochloride)
clindamycin	Injection	150 mg (as phosphate)/mL
clindamycin	oral liquid	75 mg/5 mL (as palmitate)	c1
cloxacillin	capsule	500 mg (as sodium salt)	e
cloxacillin	capsule	1 g (as sodium salt)	e
cloxacillin	Powder for injection	500 mg (as sodium salt) in vial	e
cloxacillin	powder for oral liquid	125 mg (as sodium salt)/5 mL	e
doxycycline	oral liquid	25 mg/5 ml (anhydrous)	a c1
doxycycline	oral liquid	50 mg/5 ml (anhydrous)	a c1
doxycycline	solid oral dosage form	50 mg (as hyclate)	a c1
doxycycline	solid oral dosage form	100 mg (as hyclate)	c1
doxycycline	Powder for injection	100 mg	a c1
gentamicin	Injection	10 mg (sulfate)/mL in 2-mL vial
gentamicin	Injection	40 mg (sulfate)/ml in 2-mL vial
metronidazole	Injection	500 mg in 100-mL vial
metronidazole	oral liquid	200 mg (as benzoate)/5 mL
metronidazole	Suppository	500 mg
metronidazole	Suppository	1 g
metronidazole	tablet	200 mg to 500 mg
nitrofurantoin	oral liquid	25 mg/5 ml	c1
nitrofurantoin	tablet	100 mg
phenoxymethylpenicillin	powder for oral liquid	250 mg (as potassium salt)/5 ml
phenoxymethylpenicillin	tablet	250 mg (as potassium salt)
procaine benzylpenicillin	Powder for injection	1 g (=1 million IU) in vial
procaine benzylpenicillin	Powder for injection	3 g (=3 million IU) in vial
spectinomycin	Powder for injection	2 g (as hydrochloride) in vial
sulfamethoxazole + trimethoprim	Injection	80 mg + 16 mg/mL in 5-mL ampoule
sulfamethoxazole + trimethoprim	Injection	80 mg + 16 mg/mL in 10-mL ampoule
sulfamethoxazole + trimethoprim	oral liquid	200 mg + 40 mg/5 mL
sulfamethoxazole + trimethoprim	tablet	100 mg + 20 mg
sulfamethoxazole + trimethoprim	tablet	400 mg + 80 mg
sulfamethoxazole + trimethoprim	tablet	800 mg + 160 mg

Medicamento	Forma farmacêutica	Composição	Observações
azithromycin	capsule	250 mg (anhydrous)
azithromycin	capsule	500 mg (anhydrous)
azithromycin	oral liquid	200 mg/5 mL
cefixime	oral liquid	100 mg/ 5 ml	c1
cefixime	capsule	200 mg (as trihydrate)
cefixime	capsule	400 mg (as trihydrate)
cefotaxime	Powder for injection	250 mg per vial (as sodium salt)
ceftriaxone	Powder for injection	250 mg (as sodium salt) in vial	a
cefuroxime	Powder	1.5 g (as sodium salt) in vial
cefuroxime	Powder for injection	750 mg (as sodium salt) in vial
cefuroxime	Powder for injection	250 mg (as sodium salt) in vial
ciprofloxacin	oral liquid	250 mg/5 ml (anhydrous)	c2
ciprofloxacin	Solution for IV infusion	2 mg/ml (as hyclate)	c2
ciprofloxacin	tablet	250 mg (as hydrochloride)
clarithromycin	solid oral dosage form	500 mg
clarithromycin	Powder for injection	500 mg in vial
clarithromycin	powder for oral liquid	250 mg/ 5ml
clarithromycin	powder for oral liquid	125 mg/ 5ml
piperacillin sodium + tazobactum sodium	Powder for injection	4 g + 500 mg in vial
piperacillin sodium + tazobactum sodium	Powder for injection	2 g + 250 mg in vial
vancomycin	capsule	250 mg (as hydrochloride)
vancomycin	capsule	125 mg (as hydrochloride)

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
ceftazidime	Powder for injection	250 mg or 1 g (as pentahydrate) in vial
meropenem	Powder for injection	1 g (as trihydrate) in vial	a
meropenem	Powder for injection	500 mg (as trihydrate) in vial	a
vancomycin	Powder for injection	250 mg (as hydrochloride) in vial

Medicamento	Forma farmacêutica	Composição	Observações

Lista complementar

Medicamento	Forma farmacêutica	Composição
ceftazidime + avibactam	Powder for injection	2 g + 0,5 g in vial
colistine	Powder for injection	1 million I.U. (as colistemethate sodium) in vial
linezolid	tablet	400 mg
linezolid	tablet	600 mg
linezolid	injection for intravenous administration	2 mg/ ml in 300 ml bag
linezolid	powder for oral liquid	100 mg/ 5 ml
meropenem + vaborbactam	Powder for injection	1 g + 1 g in vial
phosphomycin	Powder for injection	2 g (as sodium) in vial
phosphomycin	Powder for injection	4 g (as sodium) in vial
plazomicin	Injection	500 mg/ 10 ml
polymyxin B	Powder for injection	500.000 I.U. in vial

Medicines used in the treatment of leprosy should never be used except in combination. Combination therapy is essential to prevent the emergence of drug resistance. Colour coded blister packs (MDT blister packs) containing standard two medicine (paucibacillary leprosy) or three medicine (multibacillary leprosy) combinations for adult and childhood leprosy should be used. MDT blister packs can be supplied free of charge through WHO.

Medicamento	Forma farmacêutica	Composição
clofazimine	capsule	50 mg
clofazimine	capsule	100 mg
dapsone	tablet	25 mg
dapsone	tablet	50 mg
dapsone	tablet	100 mg
rifampicin	solid oral dosage form	150 mg
rifampicin	solid oral dosage form	300 mg

Medicamento	Forma farmacêutica	Composição	Observações
ethambutol	tablet (dispersible)	100 mg	c1
ethambutol	oral liquid	25 mg/ml	c2
ethambutol	tablet	100 mg to 400 mg (hydrochloride)
ethambutol + isoniazid + pyrazinamide + rifampicin	tablet	275 mg + 75 mg + 400 mg + 150 mg
ethambutol + isoniazid + rifampicin	tablet	275 mg + 75 mg + 150 mg
isoniazid	tablet (dispersible)	100 mg	c1
isoniazid	oral liquid	50 mg/5 ml	c2
isoniazid	tablet	100 mg to 300 mg
isoniazid	tablet (scored)	50 mg
isoniazid + pyrazinamide + rifampicin	tablet (dispersible)	50 mg + 150 mg + 75 mg	c1
isoniazid + pyrazinamide + rifampicin	tablet	75 mg + 400 mg + 150 mg
isoniazid + rifampicin	tablet (dispersible)	50 mg + 75 mg	c1
isoniazid + rifampicin	tablet	75 mg + 150 mg
isoniazid + rifampicin	tablet	150 mg + 300 mg
pyrazinamide	oral liquid	30 mg/ml	c2
pyrazinamide	tablet	400 mg
pyrazinamide	tablet (dispersible)	150 mg
pyrazinamide	tablet (scored)	150 mg
rifabutin	solid oral dosage form	150 mg
rifampicin	oral liquid	20 mg/ml	c2
rifampicin	solid oral dosage form	150 mg
rifampicin	solid oral dosage form	300 mg
rifapentine	tablet	150 mg

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
amikacin	Powder for injection	100 mg (as sulfate) in vial
amikacin	Powder for injection	500 mg (as sulfate) in vial
amikacin	Powder for injection	1 g (as sulfate) in vial
amoxicillin + clavulanic acid	tablet	500mg + 125mg
amoxicillin + clavulanic acid	oral liquid	125 mg amoxicillin + 31.25 mg clavulanic acid/5 ml	c1
amoxicillin + clavulanic acid	oral liquid	250 mg amoxicillin + 62.5 mg clavulanic acid/5 ml	c1
bedaquilina	tablet	100 mg	a
clofazimine	solid oral dosage form	50 mg
clofazimine	solid oral dosage form	100 mg
cycloserine	solid oral dosage form	125 mg	c1
cycloserine	solid oral dosage form	250 mg
delamanid	tablet	50 mg	a
ethionamide	tablet	125 mg
ethionamide	tablet	250 mg
ethionamide	tablet (dispersible)	125 mg	c1
levofloxacin	tablet	250 mg
levofloxacin	tablet	500 mg
levofloxacin	tablet	750 mg
levofloxacin	tablet (dispersible)	100 mg	c1
linezolid	injection for intravenous administration	2 mg/ ml in 300 ml bag
linezolid	powder for oral liquid	100 mg/ 5 ml
linezolid	tablet	400 mg
linezolid	tablet	600 mg
linezolid	tablet (dispersible)	150 mg	c1
meropenem	Powder for injection	500 mg (as trihydrate) in vial
meropenem	Powder for injection	1 g (as trihydrate) in vial
moxifloxacin	tablet	400 mg
moxifloxacin	tablet (dispersible)	100 mg	c1
p-aminosalicylic acid	granules	4 g in sachet
p-aminosalicylic acid	tablet	500 mg
streptomycin	Powder for injection	1 g (as sulfate) in vial	c1

Medicamento	Forma farmacêutica	Composição	Observações
amphotericin B	Powder for injection	50 mg in vial
clotrimazole	vaginal cream	1%
clotrimazole	vaginal cream	10%
clotrimazole	vaginal tablet	100 mg
clotrimazole	vaginal tablet	500 mg
fluconazole	capsule	50 mg
fluconazole	Injection	2 mg/mL in vial
fluconazole	oral liquid	50 mg/5 mL
flucytosine	capsule	250 mg
flucytosine	Infusion	2.5 g in 250 ml
griseofulvin	oral liquid	125 mg/5 ml	c2
griseofulvin	solid oral dosage form	125 mg
griseofulvin	solid oral dosage form	250 mg
itraconazole	oral liquid	10 mg/ ml
itraconazole	capsule	100 mg
nystatin	Lozenge	100 000 IU
nystatin	oral liquid	50 mg/5 ml	c1
nystatin	oral liquid	100 000 IU/ml	c1
nystatin	pessary	100 000 IU
nystatin	tablet	100 000 IU
nystatin	tablet	500 000 IU
voriconazol	tablet	50 mg
voriconazol	tablet	200 mg
voriconazol	Powder for injection	200 mg in vial
voriconazol	powder for oral liquid	40 mg/ ml

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
potassium iodide	saturated solution	N/A

Medicamento	Forma farmacêutica	Composição	Observações
aciclovir	oral liquid	200 mg/5 mL	e
aciclovir	Powder for injection	250 mg (as sodium salt) in vial	e
aciclovir	tablet	200 mg	e

Based on current evidence and experience of use, medicines in the following three classes of antiretrovirals are included as essential medicines for treatment and prevention of HIV (prevention of mother-to-child transmission and post-exposure prophylaxis). The Committee emphasizes the importance of using these products in accordance with global and national guidelines. The Committee recommends and endorses the use of fixed-dose combinations and the development of appropriate new fixed-dose combinations, including modified dosage forms, non-refrigerated products and paediatric dosage forms of assured pharmaceutical quality. Scored tablets can be used in children and therefore can be considered for inclusion in the listing of tablets, provided adequate quality products are available.

Medicamento	Forma farmacêutica	Composição	Observações
abacavir (ABC)	tablet	300 mg (as sulfate)
lamivudine (3TC)	oral liquid	50 mg/5 ml	c1
lamivudine (3TC)	tablet	150 mg
tenofovir disoproxil fumarate	tablet	300 mg
zidovudine (ZDV or AZT)	capsule	250 mg
zidovudine (ZDV or AZT)	oral liquid	50 mg/5 mL
zidovudine (ZDV or AZT)	Solution for IV infusion injection	10 mg/mL in 20-mL vial
zidovudine (ZDV or AZT)	tablet	300 mg

Medicamento	Forma farmacêutica	Composição	Observações
efavirenz (EFV or EFZ)	tablet	200 mg	a
efavirenz (EFV or EFZ)	tablet	600 mg	a
nevirapine (NVP)	tablet (dispersible)	50 mg	a
nevirapine (NVP)	oral liquid	50 mg/5 ml	a
nevirapine (NVP)	tablet	200 mg	a

Selection of protease inhibitor(s) from the Model List will need to be determined by each country after consideration of international and national treatment guidelines and experience. Ritonavir is recommended for use in combination as a pharmacological booster, and not as an antiretroviral in its own right. All other protease inhibitors should be used in boosted forms (e.g. with ritonavir).

Medicamento	Forma farmacêutica	Composição	Observações
atazanavir	solid oral dosage form	100 mg (as sulfate)	a
atazanavir	solid oral dosage form	300 mg (as sulfate)	a
atazanavir + ritonavir	tablet (heat stable)	300 mg (as sulfate) + 100 mg
darunavir	tablet	800 mg	a
darunavir	tablet	600 mg	a
darunavir	tablet	400 mg	a
darunavir	tablet	75 mg	a
lopinavir + ritonavir (LPV/r)	oral liquid	400 mg + 100 mg/5 ml
lopinavir + ritonavir (LPV/r)	tablet (heat stable)	100 mg + 25 mg
lopinavir + ritonavir (LPV/r)	tablet (heat stable)	200 mg + 50 mg
lopinavir + ritonavir (LPV/r)	solid oral dosage form	40 mg + 10 mg	c1
ritonavir	oral liquid	400 mg/5 ml
ritonavir	tablet (heat stable)	25 mg
ritonavir	tablet (heat stable)	100 mg
ritonavir	oral powder	100 mg in sachet	c1

Medicamento	Forma farmacêutica	Composição	Observações
dolutegravir	tablet	50 mg	a
raltegavir	tablet	400 mg
raltegavir	tablet (chewable)	25 mg
raltegavir	tablet (chewable)	100 mg
raltegavir	granules	100 mg in sachet

Medicamento	Forma farmacêutica	Composição
dasabuvir	tablet	250 mg
ledipasvir + sofosbuvir	tablet	90 mg/ 400 mg
ombitasvir + paritaprevir + ritonavir	tablet	12.5 mg + 75 mg + 50 mg

Medicamento	Forma farmacêutica	Composição	Observações
abacavir + lamivudine	tablet (dispersible)	120 mg (as sulfate) + 60 mg
dolutegravir + lamivudina + tenofovir disoproxil	tablet (enteric-coated)	50 mg + 300 mg + 245 mg
efavirenz + emtricitabine + tenofovir	tablet	600 mg + 200 mg + 300 mg
emtricitabine + tenofovir	tablet	200 mg + 300 mg
lamivudine + nevirapine + zidovudine	tablet	30 mg + 50 mg + 60 mg	c1
lamivudine + nevirapine + zidovudine	tablet	150 mg + 200 mg + 300 mg
lamivudine + zidovudine	tablet	30 mg + 60 mg	c1
lamivudine + zidovudine	tablet	150 mg + 300 mg
tenofovir disoproxilo + efavirenz + lamivudine	tablet	300 mg + 400 mg + 300 mg

Medicamento	Forma farmacêutica	Composição	Observações
isoniazid + pyridoxine + sulfamethoxazole + trimethoprim	tablet (scored)	300 mg + 25 mg + 800 mg + 160 mg

Medicamento	Forma farmacêutica	Composição
ribavirin	injection for intravenous administration	800 mg in 10-ml phosphate buffer solution
ribavirin	injection for intravenous administration	1 g in 10-ml phosphate buffer solution
ribavirin	solid oral dosage form	200 mg
ribavirin	solid oral dosage form	400 mg
ribavirin	solid oral dosage form	600 mg
valgancyclovir	tablet	450mg

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
oseltamivir	capsule	30 mg (as phosphate)
oseltamivir	capsule	45 mg (as phosphate)
oseltamivir	capsule	75 mg (as phosphate)
oseltamivir	oral powder	12 mg/mL
valganciclovir	Powder for solution	50 mg/ ml	c1
valgancyclovir	tablet	450mg	c1

Medicamento	Forma farmacêutica	Composição
entecavir	oral liquid	0.05 mg/ ml
entecavir	tablet	1 mg
entecavir	tablet	0.05 mg
tenofovir disoproxil fumarate	tablet	300 mg

Medicamento	Forma farmacêutica	Composição
daclatasvir	tablet	60 mg (as hydrochloride)
daclatasvir	tablet	30 mg (as hydrochloride)
glecaprevir + pibrentasvir	tablet	100 mg + 40 mg
sofosbuvir	tablet	400 mg
sofosbuvir + velpatasvir	tablet (enteric-coated)	400 mg + 100 mg.

Medicamento	Forma farmacêutica	Composição
ribavirin	solid oral dosage form	200 mg
ribavirin	solid oral dosage form	400 mg
ribavirin	solid oral dosage form	600 mg
ribavirin	injection for intravenous administration	800 mg in 10-ml phosphate buffer solution
ribavirin	injection for intravenous administration	1 g in 10-ml phosphate buffer solution

Lista complementar

Medicamento	Forma farmacêutica	Composição
pegylated interferon alfa (2a or ab)	vial or prefilled syringe	100 mcg (peginterferon alfa 2b)
pegylated interferon alfa (2a or ab)	vial or prefilled syringe	80 mcg (peginterferon alfa 2b)
pegylated interferon alfa (2a or ab)	vial or prefilled syringe	180 mcg (peginterferon alfa 2a)

Medicamento	Forma farmacêutica	Composição	Observações
diloxanide	tablet	500 mg (furoate)	a
metronidazole	Injection	500 mg in 100-mL vial	e
metronidazole	oral liquid	200 mg (as benzoate)/5 mL	e
metronidazole	tablet	200 mg to 500 mg	e

Medicamento	Forma farmacêutica	Composição
amphotericin B	Powder for injection	50 mg in vial
meglumine antimoniate	Injection	30%, equivalent to approximately 8.1% antimony (pentavalent) in 5-ml ampoule
miltefosine	solid oral dosage form	10 mg
miltefosine	solid oral dosage form	50 mg
paromomycin	solution for intramuscular injection	750 mg of paromomycin base (as the sulfate)
sodium stibogluconate	Injection	100 mg/ml, 1 vial = 30 ml

Medicines for the treatment of P. falciparum malaria cases should be used in combination. The list currently recommends combinations according to treatment guidelines. The Committee recognizes that not all of these FDCs exist and encourages their development and rigorous testing. The Committee also encourages development and testing of rectal dosage formulations.

Medicamento	Forma farmacêutica	Composição	Observações
amodiaquine	tablet	153 mg (as hydrochloride)
amodiaquine	tablet	200 mg (as hydrochloride)
artemether	Oily injection	80 mg/ml in 1-ml ampoule
artemether + lumefantrine	tablet	20 mg + 120 mg
artemether + lumefantrine	tablet (dispersible)	20 mg + 120 mg	c2
artesunate	rectal dosage form	100 mg	c1
artesunate	Injection	ampoules, containing 60 mg anhydrous artesunic acid with a separate ampoule of 5% sodium bicarbonate solution
artesunate	rectal dosage form	50 mg capsules	c2
artesunate	rectal dosage form	200 mg capsules	c2
artesunate	tablet	50 mg
artesunate + amodiaquine	tablet	25 mg + 67.5 mg
artesunate + amodiaquine	tablet	50 mg + 135 mg
artesunate + amodiaquine	tablet	100 mg + 270 mg
artesunate + mefloquine	tablet	100 mg + 220 mg
artesunate + mefloquine	tablet	25mg; 55mg
artesunate + pyronaride tetraphosphate	granules	20 mg + 60 mg	a c1
artesunate + pyronaride tetraphosphate	tablet	60 mg + 180 mg	a
chloroquine	oral liquid	50 mg (as phosphate or sulfate)/5 ml
chloroquine	tablet	100 mg (as phosphate or sulfate)
chloroquine	tablet	150 mg (as phosphate or sulfate)
dihydroartemisinin + piperaquine phosphate	tablet	40 mg + 320 mg	a
dihydroartemisinin + piperaquine phosphate	tablet	20 mg + 160 mg	a
doxycycline	capsule	100 mg (as hydrochloride or hyclate)
doxycycline	tablet (dispersible)	100 mg (as monohydrate)
mefloquine	tablet	250 mg (hydrochloride)
primaquine	tablet	7.5 mg (as diphosphate)
primaquine	tablet	15 mg (as diphosphate)
quinine	Injection	300 mg quinine hydrochloride/mL in 2-mL ampoule
quinine	tablet	300 mg (quinine sulfate)
quinine	tablet	300 mg (quinine bisulfate)
sulfadoxine + pyrimethamine	tablet	500 mg + 25 mg

Medicamento	Forma farmacêutica	Composição	Observações
amodiaquine - sulfadoxine + pyrimethamine	co-packaged dispersible tablets	76.5 mg - 250 mg + 12.5 mg	c1
amodiaquine - sulfadoxine + pyrimethamine	co-packaged dispersible tablets	153 mg - 500 mg + 25 mg	c1
chloroquine	oral liquid	50 mg (as phosphate or sulfate)/5 ml
chloroquine	tablet	150 mg (as phosphate or sulfate)
doxycycline	solid oral dosage form	100 mg (as hydrochloride or hyclate)	a
mefloquine	tablet	250 mg (hydrochloride)	a
proguanil	tablet	100 mg (as hydrochloride)
sulfadoxine + pyrimethamine	tablet	250 mg + 12.5 mg	c1
sulfadoxine + pyrimethamine	tablet	500 mg + 25 mg

Medicamento	Forma farmacêutica	Composição	Observações
pyrimethamine	tablet	25 mg
sulfadiazine	tablet	500 mg
sulfamethoxazole + trimethoprim	tablet	400 mg + 80 mg	c2
sulfamethoxazole + trimethoprim	tablet	100 mg + 20 mg
sulfamethoxazole + trimethoprim	Injection	80 mg + 16 mg/mL in 5-mL ampoule
sulfamethoxazole + trimethoprim	Injection	80 mg + 16 mg/mL in 10-mL ampoule
sulfamethoxazole + trimethoprim	tablet	800 mg + 160 mg

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
pentamidine	tablet	300 mg (as isethionate)
pentamidine	tablet	200 mg (as isethionate)

Medicamento	Forma farmacêutica	Composição	Observações
pentamidine	Powder for injection	200 mg (isetionate) in vial
suramin sodium	Powder for injection	1 g in vial

Medicamento	Forma farmacêutica	Composição
eflornithine	Injection	200 mg (hydrochloride)/ml in 100-ml bottle
melarsoprol	Injection	3.6% solution, 5-ml ampoule (180 mg of active compound)
nifurtimox	tablet	120 mg

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
melarsoprol	Injection	3.6% solution, 5-ml ampoule (180 mg of active compound)	c1

Medicamento	Forma farmacêutica	Composição	Observações
benznidazole	tablet (scored)	50 mg
benznidazole	tablet	12,5 mg	c1
benznidazole	tablet	100 mg
nifurtimox	tablet	30 mg
nifurtimox	tablet	120 mg
nifurtimox	tablet	250 mg

Medicamento	Forma farmacêutica	Composição	Observações
ivermectin	tablet (scored)	3 mg

07. Antimigraine medicines

Medicamento	Forma farmacêutica	Composição	Observações
acetylsalicylic acid	tablet	300 mg to 500 mg
ibuprofen	tablet	200 mg	c2
ibuprofen	tablet	400 mg	c2
paracetamol	oral liquid	120 mg/5 mL	c1
paracetamol	oral liquid	125 mg/5 ml	c2
paracetamol	tablet	300 mg to 500 mg

Medicamento	Forma farmacêutica	Composição	Observações
propranolol	tablet	20 mg (hydrochloride)	e
propranolol	tablet	40 mg (hydrochloride)	e

08. Antineoplastic, immunosuppressives and medicines used in Palliative care

Medicamento	Forma farmacêutica	Composição	Observações

Lista complementar

Medicamento	Forma farmacêutica	Composição
azathioprine	Powder for injection	100 mg (as sodium salt) in vial
azathioprine	tablet (scored)	50 mg
ciclosporin	capsule	25 mg
ciclosporin	concentrate for injection	50 mg/ml in 1-ml ampoule

Medicamento	Forma farmacêutica	Composição	Observações

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
arsenic trioxide	concentrate for solution for infusion	1 mg/ ml
asparaginase	Powder for injection	10 000 IU in vial
bleomycin	Powder for injection	15 mg (as sulfate) in vial
calcium folinate	tablet	5 mg
calcium folinate	tablet	25 mg
calcium folinate	Injection	3 mg/mL in 10-mL ampoule
calcium folinate	tablet	15 mg
capecitabine	tablet	150 mg
capecitabine	tablet	500 mg
carboplatin	Injection	50 mg/5 mL	e
carboplatin	Injection	150 mg/15 mL	e
carboplatin	Injection	450 mg/45 mL	e
carboplatin	Injection	600 mg/60 mL	e
chlorambucil	tablet	2 mg
cisplatin	Injection	50 mg/ 50 ml
cisplatin	Injection	100 mg/100 mL
cyclophosphamide	tablet	50 mg
cyclophosphamide	Powder for injection	500 mg in vial
cyclophosphamide	tablet	25 mg
cytarabine	Powder for injection	100 mg in vial
dacarbazine	Powder for injection	100 mg in vial
dactinomycin	Powder for injection	500 mcg in vial
dactinomycin	Powder for injection	500 mcg in vial
daunorubicin	Powder for injection	50 mg (hydrochloride) in vial
docetaxel	Injection	20 mg/ml
docetaxel	Injection	40 mg/mL
doxorubicin	Powder for injection	10 mg (hydrochloride) in vial
doxorubicin	Powder for injection	50 mg (hydrochloride) in vial
etoposide	capsule	50 mg
etoposide	capsule	100 mg
etoposide	Injection	20 mg/mL in 5-mL ampoule
fludarabine	tablet	10 mg
fludarabine	Powder for injection	50 mg (phosphate) in vial
fluorouracil	Injection	50 mg/ml in 5-ml ampoule
gemcitabine	Powder for injection	200 mg in vial
gemcitabine	Powder for injection	1 g in vial
hydroxycarbamide	solid oral dosage form	200 mg
hydroxycarbamide	solid oral dosage form	250 mg
hydroxycarbamide	solid oral dosage form	300 mg
hydroxycarbamide	solid oral dosage form	400 mg
hydroxycarbamide	solid oral dosage form	500 mg
hydroxycarbamide	solid oral dosage form	1 g
ifosfamide	Powder for injection	500 mg vial
ifosfamide	Powder for injection	1 g in vial
ifosfamide	Powder for injection	2 g in vial
irinotecan	Injection	500 mg/ 25 ml in 25 ml vial
irinotecan	Injection	100 mg/ 5 ml in 5 ml vial
irinotecan	Injection	40 mg/ 2 ml in 2 ml vial
melphalan	tablet	2 mg
melphalan	Powder for injection	50mg.
mercaptopurine	tablet	50 mg
methotrexate	Powder for injection	50 mg (as sodium salt) in vial
methotrexate	tablet	2.5 mg (as sodium salt)
oxaliplatin	Injection	50 mg/ 10 ml in 10 ml vial
oxaliplatin	Injection	100 mg/ 20 ml in 20 ml vial
oxaliplatin	Injection	200 mg/ 40 ml in 40 ml vial
oxaliplatin	Powder for injection	50 mg in vial
oxaliplatin	Powder for injection	100 mg in vial
paclitaxel	Powder for injection	6 mg/ml
pegaspargase	Injection	3.750 units/ 5 ml in vial
procarbazine	capsule	50 mg (as hydrochloride)
realgar - indigo naturalis formulation	tablet	270 mg
thioguanine	solid oral dosage form	40 mg	c1
vinblastine	Powder for injection	10 mg (sulfate) in vial
vincristine	Powder for injection	1 mg (sulfate) in vial
vincristine	Powder for injection	5 mg (sulfate) in vial
vinorelbine	Injection	10 mg/ ml in 1 ml vial
vinorelbine	Injection	50 mg/ 5 ml in 5 ml vial

Medicamento	Forma farmacêutica	Composição	Observações

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
all trans retinoid acid (ATRA)	capsule	10 mg
bortezomib	Powder for injection	3.5 mg in vial
dasatinib	tablet	20 mg
dasatinib	tablet	50 mg
dasatinib	tablet	70 mg
dasatinib	tablet	80 mg
dasatinib	tablet	100 mg
dasatinib	tablet	140 mg
erlotinib	tablet	150 mg	e
erlotinib	tablet	100 mg	e
imatinib	tablet	400 mg
imatinib	tablet	100 mg
nilotinib	capsule	200 mg
nilotinib	capsule	150 mg
rituximab	injection for intravenous administration	500 mg/ 50 ml in 50 ml vial
rituximab	injection for intravenous administration	100 mg/ 10 ml in 10 ml vial
trastuzumab	Powder for injection	60 mg in vial
trastuzumab	Powder for injection	150 mg in vial
trastuzumab	Powder for injection	440 mg in vial

Medicamento	Forma farmacêutica	Composição	Observações

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
filgrastim	Injection	120 mcg/ 0.2 ml
filgrastim	Injection	300 mcg/ 0.5 ml
filgrastim	Injection	480 mcg/ 0.8 ml in pre-filled syringe
filgrastim	Injection	300 mcg/ ml in 1 ml vial
filgrastim	Injection	480 mcg/ 1.6 ml in 1.6 ml vial
lenalidomide	capsule	25 mg
nivolumab	concentrate for solution for infusion	10 mg/ ml	e
thalidomide	capsule	50 mg

Medicamento	Forma farmacêutica	Composição	Observações

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
abiraterone	tablet	250 mg
abiraterone	tablet	N/A
anastrozole	tablet	1mg
bicalutamide	tablet	50 mg
dexamethasone	Injection	4 mg/mL in 1-mL ampoule (as disodium phosphate salt)
dexamethasone	oral liquid	2 mg/5 mL	c1
dexamethasone	tablet	4 mg
dexamethasone	tablet	2 mg	c1
hydrocortisone	Powder for injection	100 mg (as sodium succinate) in vial
leuprorelin	Injection	7.5mg (acetate)
leuprorelin	Injection	22.5 mg in pre filled syringe
methylprednisolone	Injection	40 mg/mL (as sodium succinate) in 1-mL single dose vial	c1 c2
methylprednisolone	Injection	40 mg/mL (as sodium succinate) in 5-mL multidose vials	c2
methylprednisolone	Injection	80 mg/mL (as sodium succinate) in 1-mL single dose vial	c1
prednisolone	oral liquid	5 mg/mL	c1 e
prednisolone	tablet	5 mg	e
prednisolone	tablet	25 mg	e
tamoxifen	tablet	10 mg (as citrate)
tamoxifen	tablet	20 mg (as citrate)

Medicamento	Forma farmacêutica	Composição	Observações

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
allopurinol	tablet	100 mg	c1
allopurinol	tablet	300 mg	c1
mesna	Injection	100 mg/ml in 4-ml ampoules
mesna	Injection	100 mg/ml in 10-ml ampoules
mesna	tablet	400 mg
mesna	tablet	600 mg
zoledronic acid	concentrate for solution for infusion	4 mg/ 5 ml in 5 ml vial
zoledronic acid	Solution for IV infusion	4 mg/ 100 ml in 100 ml bottle

09. Antiparkinsonism medicines

Medicamento	Forma farmacêutica	Composição	Observações
biperiden	Injection	5 mg (lactate) in 1-ml ampoule	e
biperiden	tablet	2 mg (hydrochloride)	e
levodopa + carbidopa	tablet	100 mg/ 25 mg	e
levodopa + carbidopa	tablet	100 mg + 10 mg	e
levodopa + carbidopa	tablet	250 mg + 25 mg	e

10. Medicines affecting the blood

Medicamento	Forma farmacêutica	Composição
ferrous salt	oral liquid	equivalent to 25 mg iron (as sulfate)/ml
ferrous salt	tablet	equivalent to 60 mg iron
ferrous salt + folic acid	tablet	equivalent to 60 mg iron + 400 micrograms folic acid
folic acid	tablet	400 mcg
folic acid	tablet	1 mg
folic acid	tablet	5 mg
hydroxocobalamin	Injection	1 mg (as acetate, hydrochloride or as sulfate) in 1-ml ampoule

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
erythropoiesis - stimulating agent	injection: pre- filled syringe	40000 IU/ 1 ml	e
erythropoiesis - stimulating agent	injection: pre- filled syringe	20000 IU/ 0.5 ml	e
erythropoiesis - stimulating agent	injection: pre- filled syringe	11000 IU/ 1 ml	e
erythropoiesis - stimulating agent	injection: pre- filled syringe	8000 IU/ 0.8 ml	e
erythropoiesis - stimulating agent	injection: pre- filled syringe	6000 IU/ 0.6 ml	e
erythropoiesis - stimulating agent	injection: pre- filled syringe	5000 IU/ 0.5 ml	e
erythropoiesis - stimulating agent	injection: pre- filled syringe	4000 IU/ 0.4 ml	e
erythropoiesis - stimulating agent	injection: pre- filled syringe	3000 IU/ 0.3 ml	e
erythropoiesis - stimulating agent	injection: pre- filled syringe	2000 IU/ 0.5 ml	e
erythropoiesis - stimulating agent	injection: pre- filled syringe	1000 IU/ 0.5 ml	e

Medicamento	Forma farmacêutica	Composição	Observações
dabigatran	capsule	150 mg	e
dabigatran	capsule	110 mg	e
enoxaparin	injection: pre- filled syringe	150 mg/ 1 ml
enoxaparin	injection: pre- filled syringe	120 mg/ 0.8 ml
enoxaparin	injection: pre- filled syringe	100 mg/ 1 ml
enoxaparin	injection: pre- filled syringe	80 mg/ 0.8 ml
enoxaparin	injection: pre- filled syringe	60 mg/ 0.6 ml
enoxaparin	injection: pre- filled syringe	40 mg/ 0.4 ml
enoxaparin	injection: pre- filled syringe	20 mg/ 0.2 ml
heparin sodium	Injection	1000 IU/mL in 1-mL ampoule
heparin sodium	Injection	5000 IU/mL in 1-mL ampoule
heparin sodium	Injection	20 000 IU/mL in 1-mL ampoule
phytomenadione	Injection	1 mg/mL in 5-mL ampoule	c2
phytomenadione	Injection	10 mg/mL in 5-mL ampoule
phytomenadione	tablet	10 mg
protamine sulfate	Injection	10 mg/mL in 5-mL ampoule
tranexamic acid	Injection	100 mg/ml in 10-ml ampoule
warfarin	tablet	1 mg (sodium salt)	e
warfarin	tablet	2 mg (sodium salt)	e
warfarin	tablet	5 mg (sodium salt)	e

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
desmopressin	nasal spray	10 mcg (as acetate) per dose	c1
desmopressin	Injection	4 mcg (acetate)/mL in 1 ml ampoule	c1
heparin sodium	Injection	1000 IU/mL in 1-mL ampoule	c1
heparin sodium	Injection	5000 IU/mL in 1-mL ampoule	c1
protamine sulfate	Injection	10 mg/mL in 5-mL ampoule	c1
warfarin	tablet	0.5 mg (sodium salt)	c1 e
warfarin	tablet	1 mg (sodium salt)	c1 e
warfarin	tablet	2 mg (sodium salt)	c1 e
warfarin	tablet	5 mg (sodium salt)	c1 e

Medicamento	Forma farmacêutica	Composição	Observações

Lista complementar

Medicamento	Forma farmacêutica	Composição
deferoxamine	Powder for injection	500 mg (mesilate) in vial
hydroxycarbamide	solid oral dosage form	200 mg
hydroxycarbamide	solid oral dosage form	500 mg
hydroxycarbamide	solid oral dosage form	1 g

11.BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES

Medicamento	Forma farmacêutica	Composição
fresh - frozen plasma	N/A	N/A
platelets	N/A	N/A
red blood cells	N/A	N/A
whole blood	N/A	N/A

All plasma fractions should comply with the WHO Requirements for the Collection, Processing and Quality Control of Blood, Blood Components and Plasma Derivatives (Revised 1992). (WHO Technical Report Series, No. 840, 1994, Annex 2).

Medicamento	Forma farmacêutica	Composição
anti-D immunoglobulin (human)	Injection	250 mcg in single-dose vial
antitetanus immunoglobulin (human)	Injection	500 IU in vial
rabies immunoglobulin	Injection	150 IU/ml in vial

Lista complementar

Medicamento	Forma farmacêutica	Composição
human normal immunoglobulin	intramuscular administration	16% protein solution
human normal immunoglobulin	intravenous administration	5% protein solution
human normal immunoglobulin	intravenous administration	10% protein solution
human normal immunoglobulin	subcutaneous administration	15% protein solution
human normal immunoglobulin	subcutaneous administration	16% protein solution

Medicamento	Forma farmacêutica	Composição	Observações

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
factor IX	Powder for injection	1000 UI	e
factor IX	Powder for injection	500 IU	e
factor VIII	Powder for injection	500 UI	e

Medicamento	Forma farmacêutica	Composição	Observações
dextran	Solution for injection	6%	e

Medicamento	Forma farmacêutica	Composição	Observações

12. Cardiovascular medicines

Medicamento	Forma farmacêutica	Composição	Observações
bisoprolol	tablet	1.25 mg	e
bisoprolol	tablet	5 mg	e
glyceryl trinitrate	tablet (sublingual)	500 mcg
isosorbide dinitrate	tablet (sublingual)	5 mg	e
verapamil	tablet	40 mg (hydrochloride)
verapamil	tablet	80 mg (hydrochloride)

Medicamento	Forma farmacêutica	Composição	Observações
bisoprolol	tablet	1.25 mg	e
bisoprolol	tablet	5 mg	e
digoxin	Injection	250 micrograms/mL in 2-mL ampoule
digoxin	oral liquid	50 micrograms/mL
digoxin	tablet	62.5 micrograms
digoxin	tablet	250 mcg
epinephrine (adrenaline)	Injection	100 micrograms/mL (as acid tartrate or hydrochloride) in 10-ml ampoule
lidocaine	Injection	20 mg (hydrochloride)/ml in 5-ml ampoule
verapamil	Injection	2.5 mg (hydrochloride)/mL in 2-mL ampoule
verapamil	tablet	40 mg (hydrochloride)
verapamil	tablet	80 mg (hydrochloride)

Lista complementar

Medicamento	Forma farmacêutica	Composição
amiodarone	Injection	50 mg/mL in 3-mL ampoule (hydrochloride)
amiodarone	tablet (HCI)	100 mg (hydrochloride)
amiodarone	tablet (HCI)	200 mg (hydrochloride)
amiodarone	tablet (HCI)	400 mg (hydrochloride)

Medicamento	Forma farmacêutica	Composição	Observações
amlodipine	tablet	5 mg (as maleate, mesylate or besylate)	e
bisoprolol	tablet	1.25 mg	e
bisoprolol	tablet	5 mg	e
enalapril	tablet	2.5 mg (as hydrogen maleate)	e
enalapril	tablet	5 mg (maleate)	e
hydralazine	Powder for injection	20 mg (hydrochloride) in ampoule
hydralazine	tablet	25 mg (hydrochloride)
hydralazine	tablet	50 mg (hydrochloride)
hydrochlorothiazide	oral liquid	50 mg/5 ml	e
hydrochlorothiazide	solid oral dosage form	12.5 mg	e
hydrochlorothiazide	solid oral dosage form	25 mg	e
lisinopril + amlodipine	tablet	20 mg + 10 mg	e
lisinopril + amlodipine	tablet	20 mg + 5 mg	e
lisinopril + amlodipine	tablet	10 mg + 5 mg	e
lisinopril + hydrochlorothiazide	tablet	20 mg + 25 mg	e
lisinopril + hydrochlorothiazide	tablet	20 mg + 12.5 mg
lisinopril + hydrochlorothiazide	tablet	10 mg + 12.5 mg	e
losartan	tablet	100 mg
losartan	tablet	50 mg	e
losartan	tablet	25 mg	e
methyldopa	tablet	250 mg
telmisartan + amlodipine	tablet	40 mg + 5 mg	e
telmisartan + amlodipine	tablet	80 mg + 5 mg	e
telmisartan + amlodipine	tablet	80 mg + 10 mg
telmisartan + hidroclorotiazida	tablet	80 mg/ 12.5 mg	e
telmisartan + hidroclorotiazida	tablet	40 mg + 12.5 mg	e
telmisartan + hidroclorotiazida	tablet	80 mg + 25 mg	e

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
sodium nitroprusside	Powder for infusion	50 mg in ampoule

Medicamento	Forma farmacêutica	Composição	Observações
bisoprolol	tablet	1.25 mg	e
bisoprolol	tablet	5 mg	e
digoxin	Injection	250 micrograms/mL in 2-mL ampoule
digoxin	oral liquid	50 micrograms/mL
digoxin	tablet	62.5 micrograms
digoxin	tablet	250 mcg
enalapril	tablet	2.5 mg (as hydrogen maleate)	e
enalapril	tablet	5 mg (maleate)	e
furosemide	Injection	10 mg/mL in 2-mL ampoule	e
furosemide	oral liquid	20 mg/5 mL	c2 e
furosemide	tablet	40 mg	e
hydrochlorothiazide	oral liquid	50 mg/5 ml	e
hydrochlorothiazide	solid oral dosage form	25 mg	e
losartan	tablet	25 mg	e
losartan	tablet	50mg	e
losartan	tablet	100 mg	e
spironolactone	tablet	25 mg

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
dopamine	Injection	40 mg/mL (hydrochloride) in 5-mL vial

Medicamento	Forma farmacêutica	Composição
acetylsalicylic acid	tablet	100 mg
clopidogrel	tablet	75 mg
clopidogrel	tablet	300 mg

Medicamento	Forma farmacêutica	Composição	Observações

Lista complementar

Medicamento	Forma farmacêutica	Composição
alteplase	Powder for injection	10 mg in vial
alteplase	Powder for injection	20 mg in vial
alteplase	Powder for injection	50 mg in vial
streptokinase	Powder for injection	1.5 million IU in vial

Medicamento	Forma farmacêutica	Composição	Observações
simvastatin	tablet	5 mg	e
simvastatin	tablet	10 mg	e
simvastatin	tablet	20 mg	e
simvastatin	tablet	40 mg	e

13. Dermatological medicines (topical)

Medicamento	Forma farmacêutica	Composição	Observações
miconazole	cream	2% (nitrate)	e
miconazole	Ointment	2% (nitrate)	e
selenium sulfide	detergent-based suspension	2%
sodium thiosulfate	Solution	15%
terbinafine	cream	1%
terbinafine	Ointment	1% terbinafine hydrochloride

Medicamento	Forma farmacêutica	Composição	Observações
mupirocin	cream	2 % (as mupirocin calcium)
mupirocin	Ointment	2%
potassium permanganate	aqueous solution	1:10 000
silver sulfadiazine	cream	1%	a

Medicamento	Forma farmacêutica	Composição	Observações
betamethasone	cream	0.1% (as valerate)	a e
betamethasone	Ointment	0.1% (as valerate)	a e
calamine	Lotion	N/A	e
hydrocortisone	cream	1% (acetate)	e
hydrocortisone	Ointment	1% (acetate)	e

Medicamento	Forma farmacêutica	Composição	Observações
benzoyl peroxide	cream	5%
benzoyl peroxide	Lotion	5%
coal tar	Solution	5%
fluorouracil	Ointment	5%
podophyllum resin	Solution	10% to 25%	e
salicylic acid	Solution	5%
urea	cream	5%
urea	cream	10%
urea	Ointment	5%
urea	Ointment	10%

Medicamento	Forma farmacêutica	Composição	Observações
benzyl benzoate	Lotion	25%	a e
permethrin	cream	5%
permethrin	Lotion	1%

14. Diagnostic agents

Medicamento	Forma farmacêutica	Composição	Observações
fluorescein	solution (eye drops)	1% (sodium salt)
tropicamide	solution (eye drops)	0.5%	e

Medicamento	Forma farmacêutica	Composição	Observações
amidotrizoate	Injection	140 mg to 420 mg iodine (as sodium or meglumine salt)/ml in 20-ml ampoule	e
barium sulfate	aqueous suspension	N/A
iohexol	Injection	140 mg to 350 mg iodine/ml in 5-ml ampoules	e
iohexol	Injection	140 mg to 350 mg iodine/ml in 10-ml ampoules	e
iohexol	Injection	140 mg to 350 mg iodine/ml in 20-ml ampoules	e

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
barium sulfate	aqueous suspension	N/A	c1
meglumine iotroxate	Solution	5 g to 8 g iodine in 100 ml to 250 ml	e

15. Disinfectants and antiseptics

Medicamento	Forma farmacêutica	Composição	Observações
chlorhexidine	Solution	5% (digluconate)	e
ethanol	Solution	70% (denatured)	e
polyvidone iodine	Solution	10%	e

Medicamento	Forma farmacêutica	Composição	Observações
alcohol based hand rub	Solution	ethanol 80% volume/ volume
alcohol based hand rub	Solution	isopropyl alcohol 75% volume/ volume
chlorine base compound	Powder	(0.1% available chlorine) for solution	e
chloroxylenol	Solution	4.8%	e
glutaral	Solution	2%

16. Diuretics

Medicamento	Forma farmacêutica	Composição	Observações
amiloride	tablet	5 mg (hydrochloride)
furosemide	Injection	10 mg/mL in 2-mL ampoule	e
furosemide	oral liquid	20 mg/5 mL	c2 e
furosemide	tablet	10 mg	c2 e
furosemide	tablet	20 mg	c2 e
furosemide	tablet	40 mg	e
hydrochlorothiazide	solid oral dosage form	25 mg	e
mannitol	injectable solution	10%
mannitol	injectable solution	20%
spironolactone	tablet	25 mg

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
hydrochlorothiazide	tablet (scored)	25 mg	c1 e
mannitol	injectable solution	10%	c1
mannitol	injectable solution	20%	c1
spironolactone	oral liquid	5 mg/5 ml	c1
spironolactone	oral liquid	10 mg/5 ml	c1
spironolactone	oral liquid	25 mg/5 ml	c1
spironolactone	tablet	25 mg	c1

17. Gastrointestinal medicines

Medicamento	Forma farmacêutica	Composição	Observações
omeprazole	Powder for injection	40 mg	e
omeprazole	powder for oral liquid	20 mg sachets	e
omeprazole	powder for oral liquid	40 mg sachets	e
omeprazole	solid oral dosage form	10 mg	e
omeprazole	solid oral dosage form	20 mg	e
omeprazole	solid oral dosage form	40 mg
ranitidine	Injection	25 mg/mL (as hydrochloride) in 2-mL ampoule	e
ranitidine	oral liquid	75 mg/5 mL (as hydrochloride)	e
ranitidine	tablet	150 mg (as hydrochloride)	e

Medicamento	Forma farmacêutica	Composição	Observações
dexamethasone	Injection	4 mg/mL in 1-mL ampoule (as disodium phosphate salt)
dexamethasone	oral liquid	0.5 mg/5 mL
dexamethasone	oral liquid	2 mg/5 mL
dexamethasone	solid oral dosage form	0.5 mg
dexamethasone	solid oral dosage form	0.75 mg
dexamethasone	solid oral dosage form	1.5 mg
dexamethasone	solid oral dosage form	4 mg
metoclopramide	Injection	5 mg (hydrochloride)/mL in 2-mL ampoule	a
metoclopramide	oral liquid	5 mg/5 mL	a c2
metoclopramide	tablet	10 mg (hydrochloride)	a
ondansetron	Injection	2 mg base/ml in 2-ml ampoule (as hydrochloride)	a
ondansetron	oral liquid	4 mg base/5 ml	a
ondansetron	solid oral dosage form	Eq 4 mg base	a
ondansetron	solid oral dosage form	Eq 8 mg base	a
ondansetron	solid oral dosage form	Eq 24 mg base	a

Lista complementar

Medicamento	Forma farmacêutica	Composição
aprepitant	capsule	125 mg
aprepitant	capsule	165 mg
aprepitant	powder for oral suspension	125 mg in sachet
aprepitant	capsule	80 mg

Medicamento	Forma farmacêutica	Composição	Observações
sulfasalazine	retention enema	N/A	e
sulfasalazine	Suppository	500 mg	e
sulfasalazine	tablet	500 mg	e

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
hydrocortisone	retention enema	N/A	e
hydrocortisone	Suppository	25 mg (acetate)

Medicamento	Forma farmacêutica	Composição	Observações
senna	tablet	7.5 mg (sennosides)	e

Medicamento	Forma farmacêutica	Composição
oral rehydration salts	Powder for dilution	200 ml
oral rehydration salts	Powder for dilution	500 ml
oral rehydration salts	Powder for dilution	1 L

Medicamento	Forma farmacêutica	Composição	Observações
zinc sulfate	solid oral dosage form	20 mg

18. Hormones, other endocrine medicines and contraceptives

Medicamento	Forma farmacêutica	Composição
fludrocortisone	tablet	100 mcg (acetate)
hydrocortisone	tablet	5 mg
hydrocortisone	tablet	10 mg
hydrocortisone	tablet	20 mg

Medicamento	Forma farmacêutica	Composição	Observações

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
testosterone	Injection	200 mg (enanthate) in 1-mL ampoule

Medicamento	Forma farmacêutica	Composição	Observações

Medicamento	Forma farmacêutica	Composição	Observações
medroxyprogesterone acetate	tablet	5 mg	e

Medicamento	Forma farmacêutica	Composição
insulin injection (soluble)	Injection	100 IU/ml in 10-ml vial
insulin injection (soluble)	Injection	40 IU/ml in 10-ml vial
intermediate-acting insulin	Injection	100 IU/ml in 10-ml vial
intermediate-acting insulin	Injection	40 IU/ml in 10-ml vial

Medicamento	Forma farmacêutica	Composição	Observações
gliclazide	tablet	80 mg	e
gliclazide	tablet	60 mg	e
gliclazide	tablet	30 mg	e
metformin	tablet	500 mg (hydrochloride)

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
metformin	tablet	500 mg (hydrochloride)	c1

Medicamento	Forma farmacêutica	Composição	Observações
glucagon	Injection	1 mg/mL

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
diazoxide	tablet	50 mg	c1
diazoxide	oral liquid	50 mg/ ml	c1

Medicamento	Forma farmacêutica	Composição	Observações
levothyroxine	tablet	25 mcg (sodium salt)	c2
levothyroxine	tablet	50 mcg (sodium salt)
levothyroxine	tablet	100 mcg (sodium salt)
methamizole	tablet	10 mg	e
methimazole	tablet	20 mg	e
methimazole	tablet	5 mg	e
potassium iodide	tablet	60 mg
propylthiouracil	tablet	50 mg	e

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
Lugol's solution	oral liquid	about 130 mg total iodine/ml	c1
methimazole	tablet	20 mg	c1
methimazole	tablet	10 mg	c1
methimazole	tablet	5 mg	c1
potassium iodide	tablet	60 mg	c1
propylthiouracil	tablet	50 mg	c1

19. Immunologicals

All tuberculins should comply with the WHO Requirements for Tuberculins (Revised 1985). WHO Expert Committee on Biological Standardization. Thirty-sixth report. (WHO Technical Report Series, No. 745, 1987, Annex 1).

Medicamento	Forma farmacêutica	Composição	Observações
tuberculin, purified protein derivative (PPD)	Injection	N/A

All plasma fractions should comply with the WHO Requirements for the Collection, Processing and Quality Control of Blood, Blood Components and Plasma Derivatives (Revised 1992). WHO Expert Committee on Biological Standardization. Forty-third report. (WHO Technical Report Series, No. 840, 1994, Annex 2).

Medicamento	Forma farmacêutica	Composição
antivenom immunoglobulin	Injection	N/A
diphtheria antitoxin	Injection	10 000 IU in vial
diphtheria antitoxin	Injection	20 000 IU in vial

Selection of vaccines from the Model List will need to be determined by each country after consideration of international recommendations, epidemiology and national priorities. The list below details the vaccines for which there is either a recommendation from the Strategic Advisory Group of Experts on Immunization (SAGE) (http://www.who.int/immunization/sage_conclusions/en/index.html) and/or a WHO position paper (http://www.who.int/immunization/documents/positionpapers/en/index.html). This site will be updated as new position papers are published and contains the most recent information and recommendations. All vaccines should comply with the WHO Requirements for Biological Substances.

Medicamento	Forma farmacêutica	Composição
BCG vaccine	N/A	N/A
diphtheria vaccine	N/A	N/A
haemophilus influenzae type b vaccine (Hib vaccine)	N/A	N/A
hepatitis B vaccine	N/A	N/A
HPV vaccine	N/A	N/A
measles vaccine	N/A	N/A
pertussis vaccine	N/A	N/A
pneumococcal vaccine	N/A	N/A
poliomyelitis vaccine	Powder	N/A
rotavirus vaccine	N/A	N/A
rubella vaccine	N/A	N/A
tetanus vaccine	N/A	N/A

Medicamento	Forma farmacêutica	Composição
japanese encephalitis vaccine	N/A	N/A
tick-borne encephalitis vaccine	N/A	N/A
yellow fever vaccine	N/A	N/A

Medicamento	Forma farmacêutica	Composição
influenza vaccine	N/A	N/A
mumps vaccine	N/A	N/A
varicella vaccine	N/A	N/A

Medicamento	Forma farmacêutica	Composição
cholera vaccine	N/A	N/A
dengue vaccine	N/A	N/A
hepatitis A vaccine	N/A	N/A
meningococcal meningitis vaccine	N/A	N/A
rabies vaccine	N/A	N/A
typhoid vaccine	N/A	N/A

20. Muscle relaxants (peripherally-acting) and cholinesterase inhibitors

The Expert Committee has requested a review of this section at its next meeting.

Medicamento	Forma farmacêutica	Composição	Observações
atracurium	Injection	10 mg/mL (besylate)	e
neostigmine	Injection	500 mcg in 1-mL ampoule
neostigmine	Injection	2.5 mg (metilsulfate) in 1-ml ampoule
neostigmine	tablet	15 mg (bromide)
suxamethonium	Injection	50 mg (chloride)/ml in 2-ml ampoule
suxamethonium	Powder for injection	(chloride), in vial
vecuronium	Powder for injection	10 mg (bromide)/mL in ampoule	c2 e

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
pyridostigmine	Injection	1 mg in 1-mL ampoule
pyridostigmine	tablet	60 mg (bromide)
vecuronium	Powder for injection	10 mg (bromide)/mL in ampoule	e

21. Ophthalmological preparations

This section will be reviewed at the next meeting of the Expert Committee.

Medicamento	Forma farmacêutica	Composição	Observações
aciclovir	Ointment	3% W/W
azithromycin	solution (eye drops)	1.5%
erythromycin	Ointment	0.5%	c1
gentamicin	solution (eye drops)	0.3% (sulfate)	e
natamycin	suspension (eye drops)	5%
ofloxacin	solution (eye drops)	0.3%	e
tetracycline	Eye ointment	1% (hydrochloride)	e

Medicamento	Forma farmacêutica	Composição	Observações
prednisolone	solution (eye drops)	0.5% (sodium phosphate)	e

Medicamento	Forma farmacêutica	Composição	Observações
tetracaine	solution (eye drops)	0.5% (hydrochloride)	a e

Medicamento	Forma farmacêutica	Composição	Observações
acetazolamide	tablet	250 mg
latanoprost	solution (eye drops)	50 mcg/ml
pilocarpine	solution (eye drops)	2% (hydrochloride or nitrate)	e
pilocarpine	solution (eye drops)	4% (hydrochloride or nitrate)	e
timolol	solution (eye drops)	0.25% (maleate)	e
timolol	solution (eye drops)	0.5% (maleate)	e

Medicamento	Forma farmacêutica	Composição	Observações
atropine	solution (eye drops)	0.1% (sulfate)	a c2
atropine	solution (eye drops)	0.5% (sulfate)	a c2
atropine	solution (eye drops)	1% (sulfate)	a c2

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
epinephrine (adrenaline)	solution (eye drops)	2% (as hydrochloride)

Medicamento	Forma farmacêutica	Composição	Observações

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
bevacizumab	Injection	25 mg/ml

22. Medicines For Reproductive Health And Perinatal Care

Medicamento	Forma farmacêutica	Composição	Observações
ethinylestradiol + levonorgestrel	tablet	30 mcg + 50 mcg	e
ethinylestradiol + norethisterone	tablet	35 micrograms + 1 mg	e
levonorgestrel	tablet	750 micrograms (pack of two)
levonorgestrel	tablet	1.5 mg
levonorgestrel	tablet	30 micrograms
ulipristal	tablet	30 mg (as acetate)

Medicamento	Forma farmacêutica	Composição
estradiol cypionate + medroxyprogesterone acetate	Injection	5 mg + 25 mg
medroxyprogesterone acetate	injection (intramuscular)	150 mg/ ml in 1 ml vial
medroxyprogesterone acetate	injection (subcutaneous)	104 mg/0.65 mL in pre-filled syringe or single-dose injection delivery system
norethisterone enantate	Oily solution	200 mg/ml in 1-ml ampoule

Medicamento	Forma farmacêutica	Composição	Observações
copper-containing device	N/A	N/A
levonorgestrel-releasing intrauterine system	Intrauterine system	with reservoir containing 52 mg of levonogestrel

Medicamento	Forma farmacêutica	Composição	Observações
condoms	N/A	N/A
diaphragms	N/A	N/A

Medicamento	Forma farmacêutica	Composição	Observações
etonogestrel	implant	68 mg.
levonorgestrel-releasing implant	N/A	Two-rod levonorgestrel-releasing implant, each rod containing 75 mg of levonorgestrel (150 mg total)

Medicamento	Forma farmacêutica	Composição	Observações
progesterone	vaginal ring	Progesterone-releasing vaginal ring containing 2.074 g of micronized progesterone

Medicamento	Forma farmacêutica	Composição	Observações

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
clomifene	tablet	50 mg (citrate)

Medicamento	Forma farmacêutica	Composição	Observações
carbetocin	Injection	100 mcg/ml
ergometrine	Injection	200 micrograms (hydrogen maleate) in 1-ml ampoule	e
mifepristone + misoprostol	tablet	200 mg + 200 micrograms
misoprostol	tablet	200 mcg
misoprostol	vaginal tablet	25 mcg
oxytocin	Injection	10 IU in 1-mL ampoule

Medicamento	Forma farmacêutica	Composição	Observações
nifedipine	Immediate-release capsule	10 mg

Medicamento	Forma farmacêutica	Composição	Observações
dexamethasone	Injection	4 mg/mL in 1-mL ampoule (as disodium phosphate salt)
tranexamic acid	Injection	100 mg/ml in 10-ml ampoule

Medicamento	Forma farmacêutica	Composição	Observações
caffeine citrate	Injection	20 mg/ml (equivalent to 10 mg caffeine base/ml)	c1
caffeine citrate	oral liquid	20 mg/ml (equivalent to 10 mg caffeine base/ml)	c1
chlorhexidine	Solution	4% (gluconate)	c1

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
ibuprofen	Solution for injection	5 mg/mL	c1 e
prostaglandin E	Solution for injection	Prostaglandin E1: 0.5 mg/ml in alcohol	c1 e
prostaglandin E	Solution for injection	Prostaglandin E2: 1 mg/ml	c1 e
surfactant	Suspension for intratracheal instillation	25 mg/ml	c1
surfactant	Suspension for intratracheal instillation	80 mg/ml	c1

23. Peritoneal dialysis solution

Medicamento	Forma farmacêutica	Composição	Observações

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
intraperitoneal dialysis solution (of appropriate composition)	parenteral solution	N/A

24. Medicines for mental and behavioural disorders

Medicamento	Forma farmacêutica	Composição	Observações
chlorpromazine	Injection	25 mg (hydrochloride)/mL in 2-mL ampoule	e
chlorpromazine	oral liquid	25 mg (hydrochloride)/5 mL	e
chlorpromazine	tablet	100 mg (hydrochloride)	e
clozapine	solid oral dosage form	25 to 200 mg
fluphenazine	Injection	25 mg (decanoate or enantate) in 1-mL ampoule	e
haloperidol	Injection	5 mg/mL in 1-mL ampoule	e
haloperidol	tablet	2 mg	e
haloperidol	tablet	5 mg	e
risperidone	solid oral dosage form	0.25 mg to 6.0 mg

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
chlorpromazine	Injection	25 mg (hydrochloride)/mL in 2-mL ampoule	c1
chlorpromazine	oral liquid	25 mg (hydrochloride)/5 mL	c1
chlorpromazine	tablet	10 mg (hydrochloride)	c1
chlorpromazine	tablet	25 mg (hydrochloride)	c1
chlorpromazine	tablet	50 mg (hydrochloride)	c1
chlorpromazine	tablet	100 mg (hydrochloride)	c1
haloperidol	Injection	5 mg/mL in 1-mL ampoule	c1
haloperidol	oral liquid	2 mg/mL	c1
haloperidol	solid oral dosage form	0.5 mg	c1
haloperidol	solid oral dosage form	2 mg	c1
haloperidol	solid oral dosage form	5 mg	c1

Medicamento	Forma farmacêutica	Composição	Observações
amitriptyline	tablet	25 mg (hydrochloride)	e
amitriptyline	tablet	75 mg (hydrochloride)
fluoxetine	solid oral dosage form	20 mg (as hydrochloride)

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
fluoxetine	solid oral dosage form	20 mg (as hydrochloride)	a c1

Medicamento	Forma farmacêutica	Composição
carbamazepine	tablet (scored)	100 mg
carbamazepine	tablet (scored)	200 mg
lithium carbonate	solid oral dosage form	300 mg
valproic acid (sodium valproate)	tablet (enteric-coated)	200 mg (sodium valproate)
valproic acid (sodium valproate)	tablet (enteric-coated)	500 mg (sodium valproate)

Medicamento	Forma farmacêutica	Composição	Observações
diazepam	tablet (scored)	2 mg	e
diazepam	tablet (scored)	5 mg	e

Medicamento	Forma farmacêutica	Composição	Observações
clomipramine	capsule	10 mg (hydrochloride)
clomipramine	capsule	25 mg (hydrochloride)

Medicamento	Forma farmacêutica	Composição
nicotine replacement therapy (NRT)	Chewing gum	2 mg (as polacrilex)
nicotine replacement therapy (NRT)	Chewing gum	4 mg (as polacrilex)
nicotine replacement therapy (NRT)	transdermal patches	5 mg to 30 mg/16 hrs
nicotine replacement therapy (NRT)	transdermal patches	7 mg to 21 mg/24 hrs

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
methadone	concentrate for oral liquid	5 mg/ml (hydrochloride)	e
methadone	concentrate for oral liquid	10 mg/ml (hydrochloride)	e
methadone	oral liquid	5 mg/5 ml (hydrochloride)	e
methadone	oral liquid	10 mg/5 ml (hydrochloride)	e

25. Medicines acting on the respiratory tract

Medicamento	Forma farmacêutica	Composição	Observações
beclometasone	inhalation (aerosol)	50 mcg (dipropionate) per dose (as CFC free forms)	e
beclometasone	inhalation (aerosol)	100 micrograms (dipropionate) per dose (as CFC free forms)	e
budesonide	inhalation (aerosol)	100 micrograms per dose	c2 e
budesonide	inhalation (aerosol)	200 micrograms per dose	c2 e
budesonide + formoterol	powder for inhalacion	100 mcg + 6 mcg per dose
budesonide + formoterol	powder for inhalacion	200 mcg + 6 mcg per dose
epinephrine (adrenaline)	Injection	1 mg (as hydrochloride or hydrogen tartrate) in 1-ml ampoule
ipratropium bromide	inhalation (aerosol)	20 micrograms/metered dose
salbutamol	inhalation (aerosol)	100 mcg (as sulfate) per dose	e
salbutamol	Injection	50 mcg (as sulfate)/mL in 5-mL ampoule	e
salbutamol	metered dose inhaler (aerosol)	100 mcg (as sulfate) per dose	e
salbutamol	respirator solution for use in nebulizers	5 mg (as sulfate)/mL	e
tiotropium	powder for inhalacion	18 mcg
tiotropium	capsule	18 mcg
tiotropium	solution for inhalation	1.25 mcg per actuation
tiotropium	solution for inhalation	2.5 mcg per actuation

26. Solutions correcting water, electrolyte and acid-base disturbances

Medicamento	Forma farmacêutica	Composição
oral rehydration salts	Powder for dilution	200 ml
oral rehydration salts	Powder for dilution	500 ml
oral rehydration salts	Powder for dilution	1 L
potassium chloride	Powder for solution	N/A

Medicamento	Forma farmacêutica	Composição	Observações
glucose	injectable solution	5% (isotonic)
glucose	injectable solution	10% (hypertonic)
glucose	injectable solution	50% (hypertonic)
glucose with sodium chloride	injectable solution	4% glucose, 0.18% sodium chloride (equivalent to Na+ 30 mmol/L, Cl- 30 mmol/L)
glucose with sodium chloride	injectable solution	5% glucose, 0.9% sodium chloride (equivalent to 150 mmol/L Na+ and 150 mmol/L Cl-)	c2
potassium chloride	Solution	11.2% in 20-ml ampoule (equivalent to K+ 1.5 mmol/ml, Cl 1.5 mmol/ml)
potassium chloride	Solution for dilution	7.5% (equivalent to K 1 mmol/ml and Cl 1 mmol/ml)	c2
potassium chloride	Solution for dilution	15% (equivalent to K 2 mmol/ml and Cl 2 mmol/ml)	c2
sodium chloride	injectable solution	0.9% isotonic (equivalent to Na+ 154 mmol/L, Cl- 154 mmol/L)
sodium hydrogen carbonate	injectable solution	1.4% isotonic (equivalent to Na+ 167 mmol/L, HCO3- 167 mmol/L)
sodium hydrogen carbonate	Solution	8.4% in 10-ml ampoule (equivalent to Na+ 1000 mmol/L, HCO3-1000 mmol/L)
sodium lactate, compound	injectable solution	N/A	e

Medicamento	Forma farmacêutica	Composição
water for injection	N/A	2-ml ampoules
water for injection	N/A	5-mL ampoules
water for injection	N/A	10-ml ampoules

27. Vitamins and minerals

Medicamento	Forma farmacêutica	Composição	Observações
ascorbic acid	tablet	50 mg
calcium	tablet	500 mg (elemental)
cholecalciferol	oral liquid	400 IU/ml	c2
cholecalciferol	solid oral dosage form	400 IU	c2
cholecalciferol	solid oral dosage form	1000 IU	c2
ergocalciferol	oral liquid	250 micrograms/ml (10 000 IU/ml)	e
ergocalciferol	solid oral dosage form	1.25 mg (50 000 IU)	e
iodine	capsule	190 mg
iodine	Iodized oil	1 ml (480 mg iodine) in ampoule (oral or injectable)
iodine	Iodized oil	0.5 ml (240 mg iodine) in ampoule (oral or injectable)
iodine	Iodized oil	0.57 ml (308 mg iodine) in dispenser bottle
multiple micronutrient powder	sachet	N/A	c1
nicotinamide	tablet	50 mg	e
pyridoxine	tablet	25 mg (hydrochloride)
retinol	capsule	50 000 IU (as palmitate)
retinol	capsule	100 000 IU (as palmitate)
retinol	capsule	200 000 IU (as palmitate)
retinol	oral oily solution	100 000 IU (as palmitate)/ml in multidose dispenser
retinol	tablet (sugar-coated)	10 000 IU (as palmitate)
retinol	water-miscible injection	100 000 IU (as palmitate) in 2-ml ampoule
riboflavin	tablet	5 mg
sodium fluoride	N/A	N/A
thiamine	tablet	50 mg (hydrochloride)

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
calcium gluconate	Injection	100 mg/mL in 10-mL ampoule

28. Ear, nose and throat conditions in children

Medicamento	Forma farmacêutica	Composição	Observações
acetic acid	topical	2%, in alcohol	c2
budesonide	nasal spray	100 micrograms per dose	c2
ciprofloxacin	topical	0.3% drops (as hydrochloride)	c2
xylometazoline	nasal spray	0.05%	a c2

29. Medicines for diseases of joints

Medicamento	Forma farmacêutica	Composição	Observações
allopurinol	tablet	100 mg

Medicamento	Forma farmacêutica	Composição	Observações
chloroquine	tablet	150 mg (as phosphate or sulfate)
chloroquine	tablet	100 mg (as phosphate or sulfate)

Lista complementar

Medicamento	Forma farmacêutica	Composição	Observações
azathioprine	tablet	50 mg
hydroxychloroquine	solid oral dosage form	200 mg (as sulfate)	c1
methotrexate	tablet	2.5 mg (as sodium salt)
penicillamine	solid oral dosage form	250 mg
sulfasalazine	tablet	500 mg

Medicamento	Forma farmacêutica	Composição	Observações
acetylsalicylic acid	Suppository	50 mg to 150 mg
acetylsalicylic acid	tablet	100 mg to 500 mg

01. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES (2019) 02. MEDICINES FOR PAIN AND PALLIATIVE CARE 03. Antiallergics and medicines used in anaphylaxis 04. Antidotes and other substances used in poisonings 05. Anticonvulsants/antiepileptics 06. Anti-infective medicines 07. Antimigraine medicines 08. Antineoplastic, immunosuppressives and medicines used in Palliative care 09. Antiparkinsonism medicines 10. Medicines affecting the blood 11.BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES 12. Cardiovascular medicines 13. Dermatological medicines (topical) 14. Diagnostic agents 15. Disinfectants and antiseptics 16. Diuretics 17. Gastrointestinal medicines 18. Hormones, other endocrine medicines and contraceptives 19. Immunologicals 20. Muscle relaxants (peripherally-acting) and cholinesterase inhibitors 21. Ophthalmological preparations 22. Medicines For Reproductive Health And Perinatal Care 23. Peritoneal dialysis solution 24. Medicines for mental and behavioural disorders 25. Medicines acting on the respiratory tract 26. Solutions correcting water, electrolyte and acid-base disturbances 27. Vitamins and minerals 28. Ear, nose and throat conditions in children 29. Medicines for diseases of joints